US 8926987
Replication-competent adenoviral vectors
granted A61KA61K2039/5256A61K2039/575
Quick answer
US patent 8926987 (Replication-competent adenoviral vectors) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/5256, A61K2039/575, A61K39/21